Metabolic syndrome and diabetes for the urologist

Auteurs-es

  • Neil E. Fleshner
  • Bimal Bhindi

DOI :

https://doi.org/10.5489/cuaj.2314

Résumé

Type 2 diabetes has a number of know urological consequences. Epidemiologic and clinical data suggest a link between metabolic syndrome and prostatic diseases such as benign prostatic hyperplasia (BPH) and prostate cancer. Recent studies have identified metformin as a viable treatment for patients with type 2 diabetes and prostate cancer.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Téléchargements

Publié-e

2014-08-11

Comment citer

Fleshner, N. E., & Bhindi, B. (2014). Metabolic syndrome and diabetes for the urologist. Canadian Urological Association Journal, 8(7-8), S159–61. https://doi.org/10.5489/cuaj.2314

Numéro

Rubrique

Supplement-Review